Scope:
Keywords:
Update

News on companies and Gilead Sciences

27 days ago

Analyze the latest news on companies and Gilead Sciences, extract the entire dataset or get visualizations.

Related dashboards:

Latest news

Stocks making the biggest moves midday: Boeing, Nvidia, Autodesk, Gilead Sciences and more

Read on: CNBC News link
27d ago

Stocks making the biggest moves premarket: General Mills, Gilead Sciences, Tesla and more

Read on: CNBC News link
27d ago

Boeing, Nvidia, Tesla, BYD, Tencent, Gilead, General Mills, Autodesk: Stocks in view today

Read on: Quartz link
28d ago

Gilead's new HIV med, a bird flu shot for chickens, and Hims does blood tests: Pharma news roundup

Read on: Quartz link
54d ago

Gilead Agrees to Allow Generic Version of Groundbreaking H.I.V. Shot in Poor Countries

190d ago

Gilead's tie up with generic cos may not address HIV challenge

Read on: Times of India link
194d ago

Gilead's tie up with generic cos may not address HIV challenge

Read on: Times of India link
194d ago

Ferozsons partners with Gilead for HIV drugs

Read on: Dawn link
195d ago

Dr Reddy's, Hetero ink royalty-free pact with Gilead

Read on: Times of India link
196d ago

Dr Reddy's, Hetero ink royalty-free voluntary licencing pacts with Gilead Sciences for HIV drug Lenacapavir

Read on: Times of India link
196d ago

Gilead Sciences alleges dangerous drug-counterfeiting operation at two NYC pharmacies in lawsuit

Read on: CNBC News link
239d ago

Activists Challenge Pharma Company Gilead Over HIV Medication

Read on: Global Issues link
254d ago

Stocks making the biggest moves premarket: Gilead Sciences, Sarepta Therapeutics, Nike and more

Read on: CNBC News link
299d ago

Stocks making the biggest moves midday: Gilead Sciences, Accenture, Trump Media, AMD and more

Read on: CNBC News link
300d ago

Gilead says its HIV prevention shot was 100% effective in a clinical trial

Read on: Quartz link
300d ago

CymaBay shares jumped nearly 25% to hit a record after the clinical-stage biopharmaceutical company agreed to be acquired by Gilead for $4.3 billion.

428d ago

CymaBay Therapeutics Shares Hit All-Time High on Gilead Deal

429d ago

CymaBay Therapeutics Shares Hit All-Time High on Gilead Deal

429d ago

Drugmaker Gilead to acquire CymaBay for $4.3 billion

Read on: CNBC News link
429d ago

Stocks making the biggest moves midday: Vita Coco, Archer-Daniels-Midland, Gilead Sciences and more

Read on: CNBC News link
450d ago

Stocks making the biggest moves midday: Amazon, Lennar, GoodRx, Gilead Sciences and more

Read on: CNBC News link
462d ago

Extract data

Extract all the news on this scope:

Visualize data

Trend on this scope:

Evolution through time

Source analysis:

Distribution of sources in the news

Section analysis:

Distribution of sections in the news

Current sentiment polarity: neutral (0.21)

neutral 59%
positive 32%
negative 9%

Sentiment polarity through time